To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Opioid-Sparing Ketorolac Protocol for Pain Control After Meniscus Surgery

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
October 2025

Opioid-Sparing Ketorolac Protocol for Pain Control After Meniscus Surgery

Vol: 307| Issue: 10| Number:12| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

An Opioid-Sparing Pain Protocol of Intravenous and Oral Ketorolac Reduces Opioid Consumption and Pain Levels After Arthroscopic Meniscus Surgery: A Prospective, Randomized Controlled Trial.

Arthroscopy . 2025 Jun;41(6):1989-2001.e1.

Contributing Authors:
JT Strony S Mengers L Sivasundaram M Sinkler Q Wu C Zhao A Sattar MJ Salata JE Voos MR Karns

Synopsis

Forty-eight patients with meniscal pathology undergoing arthroscopic meniscus surgery were randomized to receive oxycodone-acetaminophen alone (n = 25) or a ketorolac protocol—30 mg IV intraoperatively plus 10 mg orally every 6 hours for 3 days, with rescue oxycodone-acetaminophen (n = 23). The primary outcomes were VAS pain and opioid consumption (converted to MMEs) during postoperative days (POD...

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue